Skip to content
Home
Our Portfolio
News & Insights
Contact
Distalmotion Advances US Expansion of its DEXTER® Surgical Robot with Clinical Milestones and System Enhancements
read more
Surgical robot gets greenlight to enter the US market
read more
Distalmotion raises $150M to accelerate FDA approval and clinical experience
read more
Dexter Series E: $90M to Make Sense of Robotic Surgery
read more
Distalmotion’s surgical robot is ready for clinical use
read more
Distalmotion – Dieser Gründer entwickelt einen Roboter für Operationen
read more
Interview with Michael Friedrich, Distalmotion CEO
read more
Distalmotion’s robot wows surgeons
read more
Distalmotion facilitates the breakthrough of surgery robots
read more
Page load link
Go to Top